In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 79, Issue 1, 2011, Pages 68-75

  Jensen, L B ^a,b   Petersson, K ^a   Nielsen, H M ^b  

^a LEO PHARMA A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Barrier impaired skin; Corticosteroid; Skin penetration; SLN; Solid lipid nanoparticles; Tape stripping

Indexed keywords

BETAMETHASONE VALERATE; SOLID LIPID NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; IN VITRO STUDY; NONHUMAN; OINTMENT; SKIN; SKIN PENETRATION; STRATUM CORNEUM; SWINE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE 17-VALERATE; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; EAR; EXCIPIENTS; LIPIDS; NANOPARTICLES; OINTMENTS; PARTICLE SIZE; PERMEABILITY; POLYSORBATES; SKIN; SKIN ABSORPTION; SOLUBILITY; SURFACE-ACTIVE AGENTS; SWINE;

EID: 80052270215     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.05.012     Document Type: Article

References (47)

1. Ortiz P. Garcia, S.H. Hansen, V.P. Shah, T. Menne, and E. Benfeldt Impact of adult atopic dermatitis on topical drug penetration: assessment by cutaneous microdialysis and tape stripping Acta Derm. Venereol. 89 1 2009 33 38
2. K.C. Moon, H.I. Maibach, T. Menne, and H.I. Maibach Percutaneous absorption in diseased skin: relationship to the exogenous dermatoses Exogenous Derm. Environ. Dermatitis 17 1991 217 226
3. M. Turpeinen, N. Mashkilleyson, F. Bjorksten, and O.P. Salo Percutaneous absorption of hydrocortisone during exacerbation and remission of atopic dermatitis in adults Acta Derm. Venereol. 68 4 1988 331 335
4. R.L. Bronaugh, and R.F. Stewart Methods for in vitro percutaneous absorption studies V: permeation through damaged skin J. Pharm. Sci. 74 10 1985 1062 1066 (Pubitemid 15231321)
5. L. Simonsen, and A. Fullerton Development of an in vitro skin permeation model simulating atopic dermatitis skin for the evaluation of dermatological products Skin Pharmacol. Physiol. 20 5 2007 230 236 (Pubitemid 47312677)
6. M. Senzui, T. Tamura, K. Miura, Y. Ikarashi, Y. Watanabe, and M. Fujii Study on penetration of titanium dioxide (TiO(2)) nanoparticles into intact and damaged skin in vitro J. Toxicol. Sci. 35 1 2010 107 113
7. H.C. Korting, and M. Schaefer-Korting Carriers in the topical treatment of skin disease Handb. Exp. Pharmacol. 197 2010 435 468
8. J. Pardeike, A. Hommoss, and R.H. Muller Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Int. J. Pharm. 366 1-2 2009 170 184
9. M. Schafer-Korting, W. Mehnert, and H.C. Korting Lipid nanoparticles for improved topical application of drugs for skin diseases Adv. Drug Deliv. Rev. 59 6 2007 427 443 (Pubitemid 47259224)
10. V. Jenning, A.F. Thunemann, and S.H. Gohla Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids Int. J. Pharm. 199 2 2000 167 177 (Pubitemid 30236188)
11. Maia C. Santos, W. Mehnert, M. Schaller, H.C. Korting, A. Gysler, A. Haberland, and M. Schafer-Korting Drug targeting by solid lipid nanoparticles for dermal use J. Drug Target. 10 6 2002 489 495 (Pubitemid 35230199)
12. R.H. Muller, R.D. Petersen, A. Hommoss, and J. Pardeike Nanostructured lipid carriers (NLC) in cosmetic dermal products Adv. Drug Deliv. Rev. 59 6 2007 522 530 (Pubitemid 47271894)
13. S. Wissing, A. Lippacher, and R. Muller Investigations on the occlusive properties of solid lipid nanoparticles (SLN) J. Cosmet. Sci. 52 5 2001 313 324 (Pubitemid 33724124)
14. N. Katoh Future perspectives in the treatment of atopic dermatitis J. Dermatol. 36 7 2009 367 376
15. E. Proksch, R. Folster-Holst, and J.M. Jensen Skin barrier function, epidermal proliferation and differentiation in eczema J. Dermatol. Sci. 43 3 2006 159 169 (Pubitemid 44189201)
16. H.C. Williams Epidemiology of atopic dermatitis Clin. Exp. Dermatol. 25 7 2000 522 529 (Pubitemid 32104617)
17. A. Wollenberg, S. Kraft, T. Oppel, and T. Bieber Atopic dermatitis: pathogenetic mechanisms Clin. Exp. Dermatol. 25 7 2000 530 534 (Pubitemid 32104618)
18. M. Turpeinen, E. Lehtokoski-Lehtiniemi, S. Leisti, and O.P. Salo Percutaneous absorption of hydrocortisone during and after the acute phase of dermatitis in children Pediatr. Dermatol. 5 4 1988 276 279 (Pubitemid 19027867)
19. I. Jakasa, C.M. de Jongh, M.M. Verberk, J.D. Bos, and S. Kezic Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of patients with atopic dermatitis compared with control subjects Brit. J. Dermatol. 155 1 2006 104 109 (Pubitemid 43876401)
20. C.M. Keck, and K. Schwabe Silver-nanolipid complex for application to atopic dermatitis skin: rheological characterization, in vivo efficiency and theory of action J. Biomed. Nanotechnol. 5 4 2009 428 436
21. S. Wiedersberg, C.S. Leopold, and R.H. Guy Bioavailability and bioequivalence of topical glucocorticoids Eur. J. Pharm. Biopharm. 68 3 2008 453 466 (Pubitemid 351318206)
22. Maia C. Santos, W. Mehnert, and M. Schafer-Korting Solid lipid nanoparticles as drug carriers for topical glucocorticoids Int. J. Pharm. 196 2 2000 165 167 (Pubitemid 30105735)
23. R. Sivaramakrishnan, C. Nakamura, W. Mehnert, H.C. Korting, K.D. Kramer, and M. Schafer-Korting Glucocorticoid entrapment into lipid carriers- characterisation by parelectric spectroscopy and influence on dermal uptake J. Control. Release 97 3 2004 493 502 (Pubitemid 38802951)
24. J. Zhang, and E. Smith Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles J. Pharm. Sci. 100 3 2010 896 903
25. L.B. Jensen, E. Magnussson, L. Gunnarsson, C. Vermehren, H.M. Nielsen, and K. Petersson Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles Int. J. Pharm. 390 1 2010 53 60
26. R.H. Muller, J.S. Lucks, Arzneistofträger aus festen Lipidteilchen, Feste Lipidnanosphären (SLN), European Patent (0605497), 1996.
27. K.C. James Regular solutions Solubility Relat. Prop. 1 5 1986 149 212
28. V.V. Kumar, D. Chandrasekar, S. Ramakrishna, V. Kishan, Y.M. Rao, and P.V. Diwan Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics Int. J. Pharm. 335 1-2 2007 167 175 (Pubitemid 46482862)
29. L.H. Reddy, and R.S. Murthy Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation AAPS PharmSciTech 6 2 2005 E158 E166
30. K.B. Sloan, S.A. Koch, K.G. Siver, and F.P. Flowers Use of solubility parameters of drug and vehicle to predict flux through skin J. Invest. Dermatol. 87 2 1986 244 252 (Pubitemid 16041737)
31. Z. Liron, and S. Cohen Percutaneous absorption of alkanoic acids II: application of regular solution theory J. Pharm. Sci. 73 4 1984 538 542 (Pubitemid 14134335)
32. R.H. Muller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 Suppl. 1 2002 S131 S155
33. G. Oberdorster, E. Oberdorster, and J. Oberdorster Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ. Health Perspect. 113 7 2005 823 839 (Pubitemid 40984181)
34. F. Stracke, B. Weiss, C.M. Lehr, K. Konig, U.F. Schaefer, and M. Schneider Multiphoton microscopy for the investigation of dermal penetration of nanoparticle-borne drugs J. Invest. Dermatol. 126 10 2006 2224 2233 (Pubitemid 44413169)
35. G.M. El Maghraby, A.C. Williams, and B.W. Barry Can drug-bearing liposomes penetrate intact skin? J. Pharm. Pharmacol. 58 4 2006 415 429
36. T.W. Prow, J.E. Grice, L.L. Lin, R. Faye, M. Butler, W. Becker, E.M. Wurm, C. Yoong, T.A. Robertson, H.P. Soyer, and M.S. Roberts Nanoparticles and microparticles for skin drug delivery Adv. Drug Deliv. Rev. 63 6 2011 470 491
37. P.V. Pople, and K.K. Singh Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis Int. J. Pharm. 398 1-2 2010 165 178
38. S. Kuchler, M.R. Radowski, T. Blaschke, M. Dathe, J. Plendl, R. Haag, M. Schafer-Korting, and K.D. Kramer Nanoparticles for skin penetration enhancement - a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles Eur. J. Pharm. Biopharm. 71 2 2009 243 250
39. C.N. Palmer, A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, S.P. Lee, D.R. Goudie, A. Sandilands, L.E. Campbell, F.J. Smith, G.M. O'Regan, R.M. Watson, J.E. Cecil, S.J. Bale, J.G. Compton, J.J. DiGiovanna, P. Fleckman, S. Lewis-Jones, G. Arseculeratne, A. Sergeant, C.S. Munro, Houate B. El, K. McElreavey, L.B. Halkjaer, H. Bisgaard, S. Mukhopadhyay, and W.H. McLean Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat. Genet. 38 4 2006 441 446
40. S. Weidinger, T. Illig, H. Baurecht, A.D. Irvine, E. Rodriguez, A. Diaz-Lacava, N. Klopp, S. Wagenpfeil, Y. Zhao, H. Liao, S.P. Lee, C.N. Palmer, C. Jenneck, L. Maintz, T. Hagemann, H. Behrendt, J. Ring, M.M. Nothen, W.H. McLean, and N. Novak Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations J. Allergy Clin. Immunol. 118 1 2006 214 219 (Pubitemid 43949588)
41. S.L. Borgia, M. Regehly, R. Sivaramakrishnan, W. Mehnert, H.C. Korting, K. Danker, B. Roder, K.D. Kramer, and M. Schafer-Korting Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy J. Control. Release 110 1 2005 151 163 (Pubitemid 41713939)
42. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. Xu, and X. Yang Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting J. Control. Release 110 2 2006 296 306 (Pubitemid 41827483)
43. V. Jenning, and S. Gohla Comparison of wax and glyceride solid lipid nanoparticles (SLN) Int. J. Pharm. 196 2 2000 219 222 (Pubitemid 30105747)
44. R.J. Scheuplein Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration J. Invest. Dermatol. 48 1 1967 79 88
45. E.B. Souto, S.A. Wissing, C.M. Barbosa, and R.H. Muller Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278 1 2004 71 77 (Pubitemid 38670438)
46. V. Jenning, M. Schafer-Korting, and S. Gohla Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties J. Control. Release 66 2-3 2000 115 126 (Pubitemid 30160850)
47. J.A. Bouwstra, B.A. van den Bergh, and M. Suhonen Topical application of drugs: mechanisms involved in chemical enhancement J. Recept. Signal Transduct. Res. 21 2-3 2001 259 286 (Pubitemid 33094465)